Geistlich Leads Brazil Dental Bone Graft Substitutes Market Despite Major Competition from Off-Label Imitation Products
April 07, 2017 (PRLEAP.COM) Health NewsApril 7, 2017 - Vancouver, BC – According to a new series of reports on the Brazil dental bone graft substitutes and barrier membrane market by iData Research (www.idataresearch.com), the market is largely limited by the cost of procedures. While the vast majority of companies that distribute dental membranes strongly recommend the use of membranes in every bone grafting procedure, dentists are often hesitant to add cost and avoid the use of membranes if it is not clinically necessary.
"While membranes increase the likelihood that the procedure will be successful, they represent an additional expense that patients and insurers are not always willing to accept," explains Jeffrey Wong, Strategic Analyst Manager at iData Research. "However, the increasing preference of resorbable materials over their non-resorbable counterparts is encouraging growth in this market as bio-absorbable membranes are offered at a price premium."
An ongoing trend to deal with the high cost of dental bone graft procedures within Brazil is the continued presence of off-label sales. Offered by what has been described as "copy-cat brands", these bone grafts are labeled as generic or bioequivalent to premium brands. A common example would be an imitation of the Bio-Oss® product originally offered by Geistlich. Imitation products will continue to be a significant cornerstone of the dental market in Brazil as price sensitivity remains a major concern, greatly depressing the overall average selling price (ASP) of bone graft substitutes.
As many customers tend to rely on off-label products, the market potential is further limited by the competitive edge of these brands. New entrants into the market must face off-label sales as their major competition, which may be difficult to overcome. To counteract these imitation products and assure tissue quality, Brazil regulation agencies have tightened their guidelines. However, these guidelines tend to be intimidating as doctors are required to report and process copious amounts of information, which they would rather avoid. Bans on imported allograft products, and removal of allografts previously offered by local companies, ensure that there is no way around the hassle associated with utilizing this category of bone grafts.
The dental bone graft substitute and barrier membrane markets in Brazil are largely controlled by tissue banks and 4 main companies: Geistlich, Critéria, Baumer and Zimmer Biomet. In addition to their current dominance in the market, they are also very active with ongoing acquisitions to further secure their leading positions. Geistlich is the market leader in both the dental bone graft substitute and dental membrane markets in Brazil. Geistlich benefited from selling the most recognized brand of dental bone graft material, Bio-Oss®, which allowed it to hold significant market share in the xenograft segment. Aside from manufacturing consolidation, emerging competitors continue to gain market share through competitive pricing. Success in the Brazilian market will depend on who can capture market share based on not only price but also functionality. Examples of this include gradually emerging submarkets such as xenografts, growth factors and resorbable dental membranes. Additional competitors in the Brazil dental bone graft substitute market include Straumann, Nobel Biocare and Sistema INP among others.
For Further Information
More on the dental bone graft substitutes market in Brazil can be found in a series of reports published by iData Research entitled the Brazil Market Report Suite for Dental Bone Graft Substitutes and Other Biomaterials. The suite covers reports on the following markets: dental bone graft substitutes and dental barrier membranes as well as an appendix on the dental growth factor market.
The iData report series on dental bone graft substitutes covers the U.S., China, Australia, Japan, South Korea, Brazil, Mexico, Argentina and 15 countries in Europe including Germany, France, the United Kingdom (U.K.), Italy, Spain, Benelux (Belgium, Netherlands and Luxemburg), Scandinavia (Finland, Denmark, Sweden and Norway), Portugal, Austria and Switzerland. Reports provide a comprehensive analysis including units sold, market value, forecasts, as well as detailed competitive market shares and analysis of major players' success strategies in each market and segment. To find out more about dental bone graft substitute market data, register online or email us at firstname.lastname@example.org for a Brazil Market Report Suite for Dental Bone Graft Substitutes and Other Biomaterials brochure and synopsis.
About iData Research
iData Research (www.idataresearch.com) is an international market research and consulting firm, dedicated to providing the best in business intelligence for the medical device industry. Our research empowers our clients by providing them with the necessary tools to achieve their goals and do it right the first time. iData covers research in: Dental Operatory Equipment, Dental Material, Dental Lasers, Dental Prosthetics, Dental CAD/CAM, Dental Bone Graft Substitutes, Ophthalmics, Ultrasound, X-Ray Imaging, Diagnostic Imaging, Oncology, Vascular Access, Interventional Cardiology, Cardiac Surgery, Cardiac Rhythm Management, Electrophysiology, Operating Room Equipment, Surgical Microscopes, Robotics and Surgical Navigation, Laparoscopy, Urology, Gynecology, Endoscopy, Spinal Implants and VCF, Spinal MIS, Orthopedic Soft Tissue Repair and Regeneration, Orthopedic Trauma, Large & Small Joints, Anesthesiology, Wound Management, Orthopedics and more.
We have built a reputation and earned our clients' trust based on consistent and uniquely intelligent research that allows our customers to make confident decisions and impact their businesses. A combination of market expertise and over a decade of experience has resulted in a deep understanding of the medical device industry that has inspired innovation and propelled our clients to success.